Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Behjatolah Karbassi

Concepts (273)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Tumor-Associated, Carbohydrate
15
2023
46
3.970
 Why?
Cancer Vaccines
13
2022
103
2.700
 Why?
Peptides
17
2022
276
2.630
 Why?
Carbohydrates
14
2009
64
2.470
 Why?
Molecular Mimicry
13
2007
64
2.100
 Why?
Breast Neoplasms
12
2024
1249
1.770
 Why?
Neoplasms
9
2022
1322
1.520
 Why?
Immunotherapy
6
2022
264
1.140
 Why?
Epitopes, T-Lymphocyte
6
2009
33
0.950
 Why?
HIV Envelope Protein gp120
4
2009
22
0.880
 Why?
Lung Neoplasms
4
2014
643
0.860
 Why?
Antibodies, Neoplasm
2
2017
35
0.850
 Why?
HIV-1
4
2009
72
0.850
 Why?
Mice, Inbred BALB C
16
2011
370
0.830
 Why?
Antigens
4
2003
53
0.810
 Why?
Epithelial-Mesenchymal Transition
2
2020
53
0.690
 Why?
Animals
31
2023
14409
0.670
 Why?
Clinical Trials, Phase I as Topic
2
2017
30
0.660
 Why?
Vaccines, DNA
6
2006
22
0.650
 Why?
Immunologic Surveillance
2
2009
14
0.640
 Why?
Gene Expression Regulation, Neoplastic
5
2020
868
0.640
 Why?
HIV Antigens
3
2006
13
0.620
 Why?
Epitopes
3
2009
89
0.600
 Why?
Cell Transformation, Neoplastic
1
2018
200
0.590
 Why?
Immunity, Innate
3
2018
114
0.570
 Why?
Molecular Targeted Therapy
1
2017
128
0.550
 Why?
Antineoplastic Agents
3
2017
1300
0.550
 Why?
Neoplasm Proteins
1
2018
360
0.530
 Why?
Mice
20
2011
6428
0.510
 Why?
Biomimetic Materials
1
2014
11
0.510
 Why?
Cell Hypoxia
1
2015
87
0.510
 Why?
Epigenesis, Genetic
1
2018
399
0.500
 Why?
Estrogen Receptor alpha
1
2015
95
0.500
 Why?
Vaccines
4
2002
65
0.470
 Why?
Cross Reactions
8
2006
56
0.470
 Why?
Oligosaccharides
4
2007
45
0.460
 Why?
T-Lymphocytes
7
2010
374
0.460
 Why?
Sarcoma, Experimental
2
2004
17
0.450
 Why?
Amino Acid Sequence
9
2006
767
0.450
 Why?
Polysaccharides
2
2011
57
0.450
 Why?
Antigens, Neoplasm
5
2007
170
0.440
 Why?
Molecular Sequence Data
9
2006
980
0.440
 Why?
Isoflavones
1
2023
83
0.430
 Why?
AIDS Vaccines
3
2009
15
0.430
 Why?
Humans
35
2024
54391
0.420
 Why?
Plant Lectins
2
2010
10
0.420
 Why?
Sulfotransferases
3
2020
43
0.410
 Why?
Chondroitin Sulfates
2
2011
15
0.400
 Why?
P-Selectin
2
2011
33
0.400
 Why?
Soybean Proteins
1
2023
153
0.400
 Why?
CD8-Positive T-Lymphocytes
3
2007
116
0.390
 Why?
Fructose
1
2010
29
0.380
 Why?
Autoantigens
1
2011
64
0.380
 Why?
Carbon
1
2010
61
0.370
 Why?
Adaptive Immunity
1
2010
39
0.370
 Why?
Vaccines, Subunit
3
2006
20
0.350
 Why?
CD4-Positive T-Lymphocytes
3
2006
181
0.350
 Why?
Obesity
2
2023
1203
0.340
 Why?
Carcinoma, Ductal
1
2008
8
0.330
 Why?
Drug Delivery Systems
1
2010
151
0.330
 Why?
Proteoglycans
3
2023
96
0.320
 Why?
Mammary Neoplasms, Experimental
2
2005
135
0.310
 Why?
Interferon-gamma
4
2018
195
0.310
 Why?
Carcinoma in Situ
1
2008
74
0.310
 Why?
Cell Line, Tumor
6
2011
1551
0.300
 Why?
Dendritic Cells
3
2005
142
0.290
 Why?
T-Lymphocytes, Cytotoxic
5
2009
72
0.290
 Why?
Female
18
2024
28471
0.280
 Why?
Concanavalin A
2
2005
20
0.270
 Why?
Mammary Neoplasms, Animal
1
2005
38
0.260
 Why?
Sarcoma
1
2006
72
0.260
 Why?
HIV Infections
1
2009
394
0.260
 Why?
Ligands
5
2011
229
0.250
 Why?
MCF-7 Cells
4
2020
79
0.250
 Why?
Neoplasm Metastasis
5
2015
252
0.250
 Why?
Magnetic Resonance Spectroscopy
1
2005
255
0.250
 Why?
Acetylglucosamine
1
2004
8
0.250
 Why?
Histocompatibility Antigens Class I
1
2004
52
0.240
 Why?
Combined Modality Therapy
2
2017
693
0.230
 Why?
Immunotherapy, Active
1
2003
8
0.230
 Why?
Immunoglobulin G
2
2003
227
0.230
 Why?
Melanoma
1
2007
313
0.230
 Why?
Peptide Library
4
2005
29
0.220
 Why?
Peptide Fragments
1
2004
242
0.220
 Why?
Glycosylation
3
2010
112
0.220
 Why?
Autoantibodies
2
2018
135
0.220
 Why?
Cell Proliferation
4
2020
1097
0.210
 Why?
Antigens, Viral
1
2002
58
0.210
 Why?
Biochemistry
1
2001
5
0.200
 Why?
Apoptosis
2
2020
1302
0.200
 Why?
Enzyme-Linked Immunosorbent Assay
3
2010
314
0.200
 Why?
Antibodies, Monoclonal
5
2023
564
0.200
 Why?
Liver Neoplasms
1
2005
352
0.200
 Why?
Cell Adhesion
3
2006
171
0.190
 Why?
CHO Cells
3
2006
123
0.180
 Why?
Cricetinae
3
2006
209
0.180
 Why?
Carbamates
1
2020
21
0.180
 Why?
Adjuvants, Immunologic
2
2014
61
0.180
 Why?
Colchicine
1
2020
35
0.180
 Why?
Antineoplastic Agents, Phytogenic
1
2020
87
0.170
 Why?
Neoplastic Stem Cells
1
2020
104
0.170
 Why?
Tumor Microenvironment
2
2024
210
0.170
 Why?
Carcinoma, Ductal, Breast
1
2020
96
0.170
 Why?
Anthroposophy
1
2018
3
0.170
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2020
105
0.160
 Why?
Tumor Cells, Cultured
3
2015
477
0.160
 Why?
Gene-Environment Interaction
1
2018
44
0.160
 Why?
Antibody Formation
3
2003
69
0.160
 Why?
Cell Division
3
2006
330
0.160
 Why?
Chondroitin Sulfate Proteoglycans
2
2023
21
0.160
 Why?
Immunization
3
2004
95
0.160
 Why?
Immune Tolerance
2
2009
105
0.160
 Why?
Plant Extracts
1
2020
193
0.150
 Why?
Cell Movement
4
2020
271
0.150
 Why?
Spleen
3
2004
187
0.150
 Why?
Flow Cytometry
3
2006
547
0.150
 Why?
Clinical Trials, Phase II as Topic
1
2017
51
0.150
 Why?
Homeostasis
1
2018
223
0.150
 Why?
Forecasting
1
2017
161
0.140
 Why?
HIV Antibodies
2
2006
18
0.140
 Why?
Models, Immunological
2
2007
10
0.140
 Why?
Lectins
2
2006
17
0.130
 Why?
Interleukin-12
2
2006
37
0.130
 Why?
Membrane Proteins
2
2023
389
0.130
 Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2015
60
0.130
 Why?
Phenotype
2
2010
819
0.130
 Why?
Coculture Techniques
1
2015
159
0.130
 Why?
Drug Therapy
1
2014
50
0.120
 Why?
Transforming Growth Factor beta
1
2015
158
0.120
 Why?
Adipocytes
1
2015
128
0.120
 Why?
Antibodies
1
2014
178
0.120
 Why?
Vaccines, Conjugate
2
2005
10
0.120
 Why?
Nuclear Proteins
1
2015
253
0.110
 Why?
Cell Separation
2
2005
107
0.110
 Why?
Rats, Zucker
1
2023
74
0.110
 Why?
Scavenger Receptors, Class E
1
2015
217
0.110
 Why?
Cytotoxicity, Immunologic
2
2005
62
0.110
 Why?
Positron-Emission Tomography
1
2014
323
0.110
 Why?
Immunity, Cellular
2
2003
80
0.110
 Why?
Mice, Nude
2
2004
284
0.100
 Why?
Protein Binding
2
2005
736
0.100
 Why?
C-Reactive Protein
1
2023
159
0.100
 Why?
Injections, Intramuscular
2
2003
50
0.100
 Why?
Lymphocyte Activation
3
2001
197
0.100
 Why?
Kinetics
2
2005
692
0.100
 Why?
Mutation
1
2018
1504
0.100
 Why?
Interleukin-6
1
2023
315
0.100
 Why?
Binding Sites
2
2003
440
0.100
 Why?
Lung
1
2014
508
0.100
 Why?
Prognosis
3
2020
2126
0.100
 Why?
Microscopy, Phase-Contrast
1
2010
16
0.100
 Why?
Tumor Necrosis Factor-alpha
1
2023
435
0.100
 Why?
B-Lymphocytes
2
2002
176
0.090
 Why?
DNA Methylation
1
2015
575
0.090
 Why?
Transfection
3
2007
399
0.090
 Why?
Body Weight
1
2023
578
0.090
 Why?
Substrate Specificity
1
2010
209
0.090
 Why?
Antigens, CD
2
2003
242
0.090
 Why?
Membrane Glycoproteins
2
2003
270
0.090
 Why?
Actins
1
2010
132
0.090
 Why?
Antibodies, Catalytic
1
2009
3
0.090
 Why?
Receptors, CCR5
1
2009
9
0.090
 Why?
Neoplasm Invasiveness
1
2010
294
0.090
 Why?
Dose-Response Relationship, Drug
2
2005
1476
0.090
 Why?
Cells, Cultured
2
2003
1737
0.080
 Why?
Killer Cells, Natural
1
2009
106
0.080
 Why?
Time Factors
2
2005
3210
0.080
 Why?
Fucosyltransferases
1
2007
5
0.080
 Why?
Glycosaminoglycans
1
2007
21
0.080
 Why?
Molecular Biology
1
2007
31
0.070
 Why?
Male
3
2023
27347
0.070
 Why?
Binding Sites, Antibody
1
2006
26
0.070
 Why?
Amino Acid Motifs
1
2006
57
0.070
 Why?
Cricetulus
1
2006
102
0.070
 Why?
Heparin
1
2007
97
0.070
 Why?
Antineoplastic Agents, Alkylating
1
2006
74
0.070
 Why?
E-Selectin
1
2005
19
0.070
 Why?
Rats
1
2023
3419
0.070
 Why?
Methane
1
2005
7
0.070
 Why?
Cell Membrane
1
2007
279
0.070
 Why?
Xenograft Model Antitumor Assays
1
2006
219
0.070
 Why?
Phosphorylcholine
1
2005
18
0.070
 Why?
Hydrocarbons
1
2005
9
0.070
 Why?
Mannose
1
2005
20
0.070
 Why?
Densitometry
1
2005
17
0.070
 Why?
Wheat Germ Agglutinins
1
2005
4
0.070
 Why?
Cyclophosphamide
1
2006
172
0.070
 Why?
Surface Plasmon Resonance
1
2005
25
0.070
 Why?
Biosensing Techniques
1
2005
28
0.070
 Why?
Growth Inhibitors
1
2005
32
0.070
 Why?
Bone Marrow Cells
1
2006
232
0.070
 Why?
Glycolysis
1
2005
73
0.060
 Why?
Immunoglobulins
1
2005
89
0.060
 Why?
Genetic Variation
1
2006
253
0.060
 Why?
Calcium
1
2007
434
0.060
 Why?
Oligonucleotide Array Sequence Analysis
1
2006
474
0.060
 Why?
Antigen Presentation
1
2004
28
0.060
 Why?
Immunoglobulin Constant Regions
1
2003
3
0.060
 Why?
Bone Neoplasms
1
2006
193
0.060
 Why?
Cytosol
1
2004
101
0.060
 Why?
Endothelial Cells
1
2006
294
0.060
 Why?
Plasmids
2
2003
180
0.060
 Why?
Middle Aged
2
2020
13082
0.060
 Why?
Treatment Outcome
1
2014
5612
0.060
 Why?
Recombinant Proteins
1
2005
570
0.060
 Why?
Histocompatibility Antigens Class II
1
2003
44
0.060
 Why?
Antibodies, Viral
1
2003
124
0.060
 Why?
Cytidine Monophosphate
1
2022
4
0.060
 Why?
Th1 Cells
1
2003
50
0.060
 Why?
Immunoglobulin M
1
2003
65
0.060
 Why?
Bacterial Capsules
1
2003
22
0.060
 Why?
DNA, Neoplasm
1
2003
171
0.050
 Why?
Carbohydrate Metabolism
1
2002
31
0.050
 Why?
Antibodies, Anti-Idiotypic
1
2002
30
0.050
 Why?
Models, Chemical
1
2002
65
0.050
 Why?
L-Selectin
1
2001
7
0.050
 Why?
Calorimetry
1
2001
9
0.050
 Why?
Epitope Mapping
1
2001
12
0.050
 Why?
Carbohydrate Sequence
1
2001
21
0.050
 Why?
Thermodynamics
1
2001
43
0.050
 Why?
Binding, Competitive
1
2001
113
0.050
 Why?
Mice, Inbred CBA
1
2001
40
0.050
 Why?
Protein Structure, Secondary
1
2001
99
0.050
 Why?
Sequence Homology, Amino Acid
1
2001
180
0.050
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2000
15
0.050
 Why?
Gene Expression Profiling
1
2006
1141
0.050
 Why?
Protein Conformation
1
2001
226
0.050
 Why?
Injections, Intraperitoneal
1
2000
59
0.050
 Why?
Colchicum
1
2020
5
0.050
 Why?
Inhibitory Concentration 50
1
2020
80
0.050
 Why?
Models, Molecular
1
2001
423
0.040
 Why?
Drug Screening Assays, Antitumor
1
2020
142
0.040
 Why?
Wnt Signaling Pathway
1
2020
94
0.040
 Why?
H-2 Antigens
1
1999
5
0.040
 Why?
Receptors, Estrogen
1
2020
131
0.040
 Why?
Child, Preschool
1
2008
4158
0.040
 Why?
Transformation, Genetic
1
1998
19
0.040
 Why?
Clostridium
1
1998
18
0.040
 Why?
Glycoside Hydrolases
1
1998
27
0.040
 Why?
Genes, Reporter
1
1998
98
0.040
 Why?
Plants
1
1998
55
0.040
 Why?
Cell Survival
1
2020
657
0.040
 Why?
Survival Rate
1
2020
954
0.040
 Why?
Models, Biological
1
2001
825
0.040
 Why?
Adolescent
1
2008
6900
0.030
 Why?
Retrospective Studies
1
2008
6459
0.030
 Why?
Child
1
2008
7368
0.030
 Why?
CpG Islands
1
2015
104
0.030
 Why?
Disease Progression
1
2015
915
0.030
 Why?
RNA Interference
1
2011
195
0.020
 Why?
RNA, Small Interfering
1
2011
253
0.020
 Why?
Simian virus 40
1
2003
13
0.010
 Why?
Lymphocyte Subsets
1
2003
13
0.010
 Why?
Immunoglobulin Variable Region
1
2003
33
0.010
 Why?
Mutagenesis, Site-Directed
1
2003
117
0.010
 Why?
Sequence Deletion
1
2003
99
0.010
 Why?
Protein Structure, Tertiary
1
2003
289
0.010
 Why?
Recombinant Fusion Proteins
1
2003
206
0.010
 Why?
Down-Regulation
1
2003
388
0.010
 Why?
Up-Regulation
1
2003
509
0.010
 Why?
Radiation Chimera
1
1999
5
0.010
 Why?
HIV Envelope Protein gp160
1
1999
3
0.010
 Why?
beta 2-Microglobulin
1
1999
35
0.010
 Why?
Protein Engineering
1
1999
21
0.010
 Why?
Plants, Toxic
1
1998
12
0.010
 Why?
Enzyme Stability
1
1998
27
0.010
 Why?
Plants, Genetically Modified
1
1998
26
0.010
 Why?
Stem Cells
1
1999
194
0.010
 Why?
Hot Temperature
1
1998
199
0.010
 Why?
Signal Transduction
1
2003
1752
0.010
 Why?
Mice, Knockout
1
1999
927
0.010
 Why?
Mice, Inbred C57BL
1
1999
2001
0.010
 Why?
Muscle, Skeletal
1
1999
847
0.010
 Why?
Karbassi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (273) concept(s)
_
Co-Authors Expand Description
See all (8) people
_
Similar People Expand Description
See all (33) people
_
Same Department Expand Description
Search Department